Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective is to demonstrate the efficacy and safety of multiple-dose application of three different oral doses of CG5503 IR compared to placebo and to assess safety and tolerability of CG5503 IR in women undergoing abdominal hysterectomy.
Critère d'inclusion
- Postoperative pain following abdominal hysterectomy